Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.

Juraschek SP, Steffes MW, Selvin E.

Clin Chem. 2012 Dec;58(12):1648-55. doi: 10.1373/clinchem.2012.188367. Epub 2012 Sep 27.

2.

Alternative markers of hyperglycemia and risk of diabetes.

Juraschek SP, Steffes MW, Miller ER 3rd, Selvin E.

Diabetes Care. 2012 Nov;35(11):2265-70. doi: 10.2337/dc12-0787. Epub 2012 Aug 8.

3.

Nontraditional markers of glycemia: associations with microvascular conditions.

Selvin E, Francis LM, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, Steffes MW.

Diabetes Care. 2011 Apr;34(4):960-7. doi: 10.2337/dc10-1945. Epub 2011 Feb 18.

4.

Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Parrinello CM, Selvin E.

Curr Diab Rep. 2014;14(11):548. doi: 10.1007/s11892-014-0548-3. Review.

5.

Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A.

Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.

6.

Racial differences in glycemic markers: a cross-sectional analysis of community-based data.

Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL.

Ann Intern Med. 2011 Mar 1;154(5):303-9. doi: 10.7326/0003-4819-154-5-201103010-00004.

8.

Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.

Konya J, Ng JM, Cox H, Cooke M, Lewis N, Bhandari S, Atkin SL, Kilpatrick ES.

Diabet Med. 2013 Oct;30(10):1250-4. doi: 10.1111/dme.12249. Epub 2013 Jul 9.

PMID:
23758176
9.

Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.

Chan CL, Pyle L, Kelsey M, Newnes L, Zeitler PS, Nadeau KJ.

Pediatr Diabetes. 2016 May;17(3):206-11. doi: 10.1111/pedi.12258. Epub 2015 Feb 5.

PMID:
25652226
10.

The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.

Beck R, Steffes M, Xing D, Ruedy K, Mauras N, Wilson DM, Kollman C; Diabetes Research in Children Network (DirecNet) Study Group.

Pediatr Diabetes. 2011 Dec;12(8):690-5. doi: 10.1111/j.1399-5448.2011.00764.x. Epub 2011 Apr 17.

11.

Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.

Sarwar N, Aspelund T, Eiriksdottir G, Gobin R, Seshasai SR, Forouhi NG, Sigurdsson G, Danesh J, Gudnason V.

PLoS Med. 2010 May 25;7(5):e1000278. doi: 10.1371/journal.pmed.1000278. Review.

12.

Comparative associations of diabetes risk factors with five measures of hyperglycemia.

Poon AK, Juraschek SP, Ballantyne CM, Steffes MW, Selvin E.

BMJ Open Diabetes Res Care. 2014 Apr 8;2(1):e000002. doi: 10.1136/bmjdrc-2013-000002. eCollection 2014.

13.

Glycated albumin in diabetic patients with chronic kidney disease.

Zheng CM, Ma WY, Wu CC, Lu KC.

Clin Chim Acta. 2012 Oct 9;413(19-20):1555-61. doi: 10.1016/j.cca.2012.04.025. Epub 2012 May 10. Review.

PMID:
22579765
14.

Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.

Chon S, Lee YJ, Fraterrigo G, Pozzilli P, Choi MC, Kwon MK, Chin SO, Rhee SY, Oh S, Kim YS, Woo JT.

Diabetes Technol Ther. 2013 Jun;15(6):455-60. doi: 10.1089/dia.2012.0315. Epub 2013 Apr 25.

15.

Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.

Malmström H, Walldius G, Grill V, Jungner I, Gudbjörnsdottir S, Hammar N.

PLoS One. 2014 Oct 29;9(10):e111463. doi: 10.1371/journal.pone.0111463. eCollection 2014.

16.

Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.

Selvin E, Rawlings AM, Lutsey PL, Maruthur N, Pankow JS, Steffes M, Coresh J.

Circulation. 2015 Jul 28;132(4):269-77. doi: 10.1161/CIRCULATIONAHA.115.015415. Epub 2015 May 28.

17.

Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.

Selvin E, Rawlings AM, Grams M, Klein R, Steffes M, Coresh J.

Clin Chem. 2014 Nov;60(11):1409-18. doi: 10.1373/clinchem.2014.229427. Epub 2014 Sep 8.

18.

1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.

Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S.

Diabetes Care. 2006 Jun;29(6):1214-9.

PMID:
16731998
19.
20.

Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus.

Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA.

Pediatr Diabetes. 2007 Aug;8(4):214-9.

PMID:
17659063

Supplemental Content

Support Center